StonvexLoading…
StonvexStonvexStonvexCore line items from EXPO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-02 | Annual 2025 2025-01-03 | Annual 2023 2023-12-29 | Annual 2022 2022-12-30 |
|---|---|---|---|---|
Revenue | $582.01M | $558.51M | $536.77M | $513.29M |
Operating Income | $119.79M | $119.56M | $111.32M | $140.84M |
Net Income | $106.01M | $109.00M | $100.34M | $102.33M |
EPS (Diluted) | $2.07 | $2.11 | $1.94 | $1.96 |
Total Assets | $777.52M | $777.27M | $646.78M | $586.66M |
Total Liabilities | $387.18M | $356.20M | $290.69M | $265.91M |
Cash & Equivalents | $221.93M | $258.90M | $187.15M | $161.46M |
Free Cash Flow OCF − CapEx | $122.34M | $137.60M | $111.00M | $81.76M |
Shares Outstanding | 51.24M | 51.57M | 51.63M | 52.28M |